Andy C. Rawstron
Impact in
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
Papers in
- Genetics 128
- Chronic Lymphocytic Leukemia Research 120
-
- Lymphoma Diagnosis and Treatment 83
- Co-authors
- Peter Hillmen (65 shared papers)Roger G. Owen (46 shared papers)Gareth J. Morgan (44 shared papers)Stephen J. Richards (19 shared papers)Andrew Jack (28 shared papers)Faith E. Davies (31 shared papers)Ben Kennedy (10 shared papers)J. A. Child (19 shared papers)
- Journals
- Blood (62 papers)British Journal of Haematology (26 papers)Annals of the Rheumatic Diseases (12 papers)Cytometry Part B Clinical Cytometry (9 papers)Leukemia (8 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Andy C. Rawstron
187 papers receiving 7.2k citations
Peers
Comparison fields: 5 of 103
- Genetics 3.9k
- Hematology 3.0k
- Pathology and Forensic Medicine 3.0k
- Immunology 2.9k
- Oncology 1.6k
Countries citing papers authored by Andy C. Rawstron
This map shows the geographic impact of Andy C. Rawstron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy C. Rawstron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy C. Rawstron more than expected).
Fields of papers citing papers by Andy C. Rawstron
This network shows the impact of papers produced by Andy C. Rawstron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy C. Rawstron. The network helps show where Andy C. Rawstron may publish in the future.
Co-authors
The 25 scholars most cited alongside Andy C. Rawstron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 196 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 371 | |
| 2 | 2016 | 330 | |
| 3 | 2005 | 293 | |
| 4 | 2013 | 285 | |
| 5 | 2005 | 261 | |
| 6 | 2002 | 224 | |
| 7 | 2010 | 203 | |
| 8 | 2001 | 190 | |
| 9 | 2019 | 180 | |
| 10 | 2011 | 177 | |
| 11 | 2008 | 166 | |
| 12 | 2002 | 156 | |
| 13 | 2002 | 156 | |
| 14 | 1997 | 151 | |
| 15 | 2004 | 139 | |
| 16 | 2010 | 136 | |
| 17 | 2002 | 136 | |
| 18 | 2009 | 121 | |
| 19 | 2012 | 119 | |
| 20 | 2015 | 114 |
About Andy C. Rawstron
Andy C. Rawstron is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Hematology and Molecular Biology, having authored 196 papers that have together received 7.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (120 papers), Lymphoma Diagnosis and Treatment (83 papers), Immunodeficiency and Autoimmune Disorders (60 papers), Multiple Myeloma Research and Treatments (55 papers), Monoclonal and Polyclonal Antibodies Research (23 papers), Protein Degradation and Inhibitors (16 papers), Chronic Myeloid Leukemia Treatments (15 papers) and Cancer Treatment and Pharmacology (12 papers). The work is most often cited by research in Genetics (3.9k citations), Hematology (3.0k citations), Pathology and Forensic Medicine (3.0k citations), Immunology (2.9k citations) and Oncology (1.6k citations). Andy C. Rawstron has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Peter Hillmen, Roger G. Owen, Gareth J. Morgan, Stephen J. Richards, Andrew Jack, Faith E. Davies, Ben Kennedy, J. A. Child, Paul Emery and Edward M Vital. Their work appears in journals such as Blood, British Journal of Haematology, Annals of the Rheumatic Diseases, Cytometry Part B Clinical Cytometry and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.